)
Apogee Therapeutics (APGE) investor relations material
Apogee Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Voting matters and shareholder proposals
Election of three Class III directors for terms expiring in 2029, with nominees Mark C. McKenna, Jennifer Fox, and William (BJ) Jones, Jr. recommended by the board.
Advisory vote to approve the compensation of named executive officers as disclosed in the proxy statement.
Ratification of Ernst & Young LLP as the independent registered public accounting firm for the year ending December 31, 2026.
Additional business may be addressed if properly brought before the meeting or any adjournment.
Board of directors and corporate governance
Board recommends all three director nominees for election to serve until 2029.
Executive compensation and say-on-pay
Shareholders are asked to approve, on a non-binding advisory basis, the compensation of named executive officers.
- Proxy covers director elections, auditor ratification, say-on-pay, and strong governance practices.APGE
Proxy filing24 Apr 2026 - Sustained, deepening efficacy and safety achieved with infrequent dosing over 52 weeks.APGE
Study result23 Mar 2026 - Quarterly and semi-annual dosing data for atopic dermatitis expected soon, with phase 3 launch this year.APGE
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - Zumilokibart targets best-in-class efficacy and dosing in AD, with pivotal data expected in 2026.APGE
Corporate presentation3 Mar 2026 - Strong pipeline progress and robust cash reserves position for key data and trial milestones in 2026.APGE
Q4 20252 Mar 2026 - Quarterly dosing, rapid itch relief, and strong safety set up a 2029 launch to challenge market leaders.APGE
Guggenheim Securities Emerging Outlook: Biotech Summit 202612 Feb 2026 - 777 targets infrequent dosing, rapid relief, and broad market expansion in AD and asthma.APGE
Citi Annual Global Healthcare Conference 20253 Feb 2026 - Advancing extended-dosing biologics and combinations for I&I, with accelerated, data-driven development.APGE
Goldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026 - Optimized antibody combinations target broad inflammation, with rapid, disciplined clinical development.APGE
Jefferies Global Healthcare Conference1 Feb 2026
Next Apogee Therapeutics earnings date
Next Apogee Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage